M&T Bank
CLB icon

M&T Bank’s Core Laboratories CLB Stock Holding History

M&T Bank’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,903
Closed -$415K – 1439
2019
Q3 		$415K Buy
+8,903
New +$414K ﹤0.01% 1033
2019
Q2 		– Sell
-33,243
Closed -$2.29M – 1618
2019
Q1 		$2.29M Sell
33,243
-8,011
-19% -$537K 0.01% 490
2018
Q4 		$2.46M Sell
41,254
-5,524
-12% -$477K 0.01% 443
2018
Q3 		$5.42M Buy
46,778
+850
+2% +$95.9K 0.03% 329
2018
Q2 		$5.8M Buy
45,928
+224
+0.5% +$27.3K 0.03% 320
2018
Q1 		$4.95M Sell
45,704
-369
-0.8% -$40.8K 0.03% 353
2017
Q4 		$5.05M Buy
46,073
+106
+0.2% +$10.6K 0.03% 345
2017
Q3 		$4.54M Buy
45,967
+2,112
+5% +$205K 0.02% 358
2017
Q2 		$4.44M Buy
43,855
+412
+0.9% +$44.4K 0.03% 350
2017
Q1 		$5.02M Buy
43,443
+5,914
+16% +$687K 0.03% 327
2016
Q4 		$4.5M Buy
37,529
+6,090
+19% +$674K 0.03% 342
2016
Q3 		$3.53M Buy
31,439
+11,543
+58% +$1.33M 0.02% 387
2016
Q2 		$2.46M Buy
19,896
+2,594
+15% +$313K 0.02% 476
2016
Q1 		$1.95M Sell
17,302
-486
-3% -$50.5K 0.01% 550
2015
Q4 		$1.93M Buy
17,788
+1,416
+9% +$162K 0.01% 574
2015
Q3 		$1.64M Sell
16,372
-18,600
-53% -$2.02M 0.01% 634
2015
Q2 		$3.99M Sell
34,972
-15,822
-31% -$1.92M 0.02% 402
2015
Q1 		$5.31M Buy
50,794
+10
+0% +$1.06K 0.03% 356
2014
Q4 		$6.11M Sell
50,784
-192
-0.4% -$25.2K 0.04% 333
2014
Q3 		$7.46M Buy
50,976
+46,243
+977% +$7.14M 0.05% 286
2014
Q2 		$791K Buy
4,733
+1,027
+28% +$183K 0.03% 337
2014
Q1 		$735K Buy
3,706
+332
+10% +$62.7K 0.03% 334
2013
Q4 		$644K Sell
3,374
-2,033
-38% -$378K 0.03% 350
2013
Q3 		$915K Sell
5,407
-2,300
-30% -$357K 0.04% 259
2013
Q2 		$1.17M Buy
+7,707
New +$1.09M 0.06% 232

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

M&T Bank's CLB Position: Q4 2019 in Review

M&T Bank sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 8,903 shares — an estimated $415K sold.

M&T Bank first reported a position in CLB in Q2 2013 and held it in 25 quarters. The position peaked at $7.46M in Q3 2014. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • M&T Bank reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • M&T Bank sold 8,903 Core Laboratories shares in Q4 2019, an estimated $415K.
  • M&T Bank first reported a position in Core Laboratories in Q2 2013 and held it in 25 quarters.
  • M&T Bank's Core Laboratories position peaked at $7.46M in Q3 2014.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on M&T Bank's 13F filing for Q4 2019, filed 7 Feb 2020.